NFE2L2 and neurodegenerative disease: Nrf2-mediated neuroprotection is primarily conferred by astrocytes [12,13], and selective overexpression of Nrf2 under an astrocyte-specific promoter leads to the increased survival in mouse models of neurodegenerative diseases [14,15].